Shanghai SDIC Pioneer Fund

Shanghai SDIC Pioneer Fund (上海国投先导) is a state-linked investment fund that operates as a co-lead or follow-on investor in technology and healthcare ventures. It co-hosted an AI for Science salon in mid-2026 with FreeS Fund and Caohejing AI Accelerator at Shanghai's Caohejing Development Zone , and its deputy general manager He Miao (何苗) has appeared as a moderator at industry events . In February 2026, it made a follow-on investment in CasCade Therapeutics' nearly 500 million yuan round alongside investors including China Life Capital and QingSong Capital, having led an earlier round in the nuclear receptor and GPCR drug developer .

The fund sits within Shanghai's broader state-backed ecosystem: the Shanghai Angel Investment Guidance Fund, established in 2014 under the municipal NDRC, had reached 3.5 billion yuan in total managed scale as of October 2024 and approved over 140 sub-funds, including partnerships with FreeS Fund and others . Shanghai SDIC Pioneer Fund appears to function as a downstream, more deployment-oriented vehicle in this structure, though elsewhere's corpus does not contain detailed disclosure of its own AUM, vintage, or full mandate.